Hamada Hashem
Impact in
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
-
- Antibiotic Resistance in Bacteria
Papers in
-
- Cancer therapeutics and mechanisms 11
- Enzyme function and inhibition 2
-
- Synthesis and biological activity 5
- Synthesis and Biological Evaluation 4
- Co-authors
- Gamal El‐Din A. Abuo‐Rahma (9 shared papers)Samar H. Abbas (6 shared papers)Elshimaa M. N. Abdelhafez (4 shared papers)Amer Ali Abd El‐Hafeez (2 shared papers)Emad I. Wafa (3 shared papers)Kareem Ebeid (3 shared papers)Aliasger K. Salem (3 shared papers)Alaa M. Hayallah (2 shared papers)
- Journals
- Pharmaceuticals (2 papers)International Journal of Molecular Sciences (2 papers)Current Medicinal Chemistry (1 paper)Frontiers in Cellular and Infection Microbiology (1 paper)Frontiers in Chemistry (1 paper)
- Partner nations
- EgyptSaudi ArabiaGermany
In The Last Decade
Hamada Hashem
16 papers receiving 283 citations
Peers
Comparison fields: 5 of 54
- Toxicology 30
- Molecular Medicine 33
- Organic Chemistry 141
- Pharmacology 36
- Molecular Biology 154
Countries citing papers authored by Hamada Hashem
This map shows the geographic impact of Hamada Hashem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamada Hashem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamada Hashem more than expected).
Fields of papers citing papers by Hamada Hashem
This network shows the impact of papers produced by Hamada Hashem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamada Hashem. The network helps show where Hamada Hashem may publish in the future.
Co-authors
The 25 scholars most cited alongside Hamada Hashem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 47 | |
| 2 | 2018 | 46 | |
| 3 | 2016 | 40 | |
| 4 | 2019 | 27 | |
| 5 | 2023 | 23 | |
| 6 | 2022 | 18 | |
| 7 | 2019 | 17 | |
| 8 | 2025 | 15 | |
| 9 | 2023 | 15 | |
| 10 | 2024 | 14 | |
| 11 | 2023 | 14 | |
| 12 | 2025 | 3 | |
| 13 | 2025 | 3 | |
| 14 | 2025 | 2 | |
| 15 | 2025 | 2 | |
| 16 | 2025 | 1 | |
| 17 | 2025 | 0 | |
| 18 | 2025 | 0 |
About Hamada Hashem
Hamada Hashem is a scholar working on Molecular Biology, Organic Chemistry, Toxicology, Pharmacology and Oncology, having authored 18 papers that have together received 287 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (11 papers), Synthesis and biological activity (5 papers), Bioactive Compounds and Antitumor Agents (4 papers), Synthesis and Biological Evaluation (4 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Cancer-related Molecular Pathways (2 papers), Antibiotic Resistance in Bacteria (2 papers) and Enzyme function and inhibition (2 papers). The work is most often cited by research in Toxicology (30 citations), Molecular Medicine (33 citations), Organic Chemistry (141 citations), Pharmacology (36 citations) and Molecular Biology (154 citations). Hamada Hashem has collaborated with scholars based in Egypt, Saudi Arabia and Germany. Frequent co-authors include Gamal El‐Din A. Abuo‐Rahma, Samar H. Abbas, Elshimaa M. N. Abdelhafez, Amer Ali Abd El‐Hafeez, Emad I. Wafa, Kareem Ebeid, Aliasger K. Salem, Alaa M. Hayallah, Masayoshi Arai and James M. Berger. Their work appears in journals such as Pharmaceuticals, International Journal of Molecular Sciences, Current Medicinal Chemistry, Frontiers in Cellular and Infection Microbiology and Frontiers in Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.